Our results suggest that GNG5 may participate in the malignant progression of glioma through ECM-receptor interaction, toll-like receptor pathway, and the nod-like receptor signaling pathways, which are reported to be related to the immune response process [55, 56]. This evidence concerns the gene GNG5 and glioma.